Caribou Biosciences Inc (CRBU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 3,464 | 2,429 | 3,558 | 23,662 | 3,755 |
| Gross Profit | 3,464 | 2,429 | 3,558 | 23,662 | 3,755 |
| Operating Expenses | 46,965 | 48,431 | 41,000 | 38,295 | 36,623 |
| Operating Income | -43,501 | -46,002 | -37,442 | -14,633 | -32,868 |
| Other Income | 5,804 | 4,768 | 3,130 | 4,631 | 3,349 |
| Pre-tax Income | -37,697 | -41,234 | -34,312 | -10,002 | -29,519 |
| Net Income Continuous | -37,697 | -41,234 | -34,505 | -10,002 | -29,519 |
| Net Income | $-37,697 | $-41,234 | $-34,505 | $-10,002 | $-29,519 |
| EPS Basic Total Ops | -0.42 | -0.46 | -0.32 | -0.12 | -0.48 |
| EPS Basic Continuous Ops | -0.42 | -0.46 | -0.32 | -0.12 | -0.48 |
| EPS Diluted Total Ops | -0.42 | -0.46 | -0.32 | -0.12 | -0.48 |
| EPS Diluted Continuous Ops | -0.42 | -0.46 | -0.32 | -0.12 | -0.48 |
| EPS Diluted Before Non-Recurring Items | -0.42 | -0.46 | -0.39 | N/A | N/A |
| EBITDA(a) | $-43,591 | $-46,831 | $-35,085 | $-15,498 | $-34,355 |